Gilead shares rise on report of AstraZeneca's interest in megamerger
Published
Shares of Gilead Sciences Inc rose as much as 3% on Monday after a report said the U.S. drugmaker had been approached by Britain's AstraZeneca for a possible merger to form one of the world's largest drug companies.
Full Article